Study Details

Back
Study ID 015K-CL-PK13
Study Title A Phase 1b, Open-Label, Single Sequence, Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Subjects with Rheumatoid Arthritis
Clinicaltrials.gov Identifier NCT01754805
Compound Name ASP015K / peficitinib hydrobromide
Medical Indication or Disease Rheumatoid arthritis
Study Sponsor Astellas Pharma Global Development, Inc (APGD)
Collaborator Not Applicable
Study Start Date 22-Jan-2010
Study Completion Date 25-Mar-2010
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS